[go: up one dir, main page]

Zhao et al., 2013 - Google Patents

MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice

Zhao et al., 2013

View HTML
Document ID
3153538232921262041
Author
Zhao J
Rao D
O’Connell R
Garcia-Flores Y
Baltimore D
Publication year
Publication venue
Elife

External Links

Snippet

During inflammation and infection, hematopoietic stem and progenitor cells are stimulated to proliferate and differentiate into mature immune cells, especially of the myeloid lineage. MicroRNA-146a (miR-146a) is a critical negative regulator of inflammation. Deletion of miR …
Continue reading at elifesciences.org (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Zhao et al. MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
Young et al. A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment
Seach et al. Double positive thymocytes select mucosal-associated invariant T cells
Cheng et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Sinclair et al. CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells
Peligero-Cruz et al. IL18 signaling promotes homing of mature Tregs into the thymus
Cui et al. A circulating subset of iNKT cells mediates antitumor and antiviral immunity
Miyagi et al. The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells
Kurkewich et al. The mirn23a microRNA cluster antagonizes B cell development
Li et al. Temporal expression of Bim limits the development of agonist-selected thymocytes and skews their TCRβ repertoire
Dunbar et al. Jak2V617F reversible activation shows its essential requirement in myeloproliferative neoplasms
Lin et al. Oleic acid availability impacts thymocyte preprogramming and subsequent peripheral Treg cell differentiation
Lee et al. Hematopoietic stem cells temporally transition to thrombopoietin dependence in the fetal liver
Plumb et al. Interleukin‐7 in the transition of bone marrow progenitors to the thymus
Gao et al. SOCS3 expression by thymic stromal cells is required for normal T cell development
Bushnell et al. Natural killer cell regulation of breast cancer stem cells mediates metastatic dormancy
Lordo et al. Acute myeloid leukemia alters group 1 innate lymphoid cell differentiation from a common precursor
von Wnuck Lipinski et al. Hepatocyte nuclear factor 1A is a cell-intrinsic transcription factor required for B cell differentiation and development in mice
Tintelnot et al. Arc/Arg3. 1 defines dendritic cells and Langerhans cells with superior migratory ability independent of phenotype and ontogeny in mice
Chan et al. Arhgef2 regulates mitotic spindle orientation in hematopoietic stem cells and is essential for productive hematopoiesis
Kunze-Schumacher et al. miRNA miR-21 is largely dispensable for intrathymic T-cell development
Yu et al. Foxm1 haploinsufficiency drives clonal hematopoiesis and promotes a stress-related transition to hematologic malignancy in mice
US20150353897A1 (en) Method of generating multilineage potential cells
Okuyama et al. A mutant BCL11B-N440K protein interferes with BCL11A function during T lymphocyte and neuronal development
Xiong et al. The experimental research of pregnancy immune tolerance induced by FTY720 via blocking S1P signal transduction pathway